The Impact of Social Anxiety on Adolescents Diagnosed With Primary Headache: A Case-control Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-18
SponsorKonya Necmettin Erbakan Üniversitesi
About this trial
This case-control study will examine whether adolescents aged 12-18 years with a diagnosis of primary headache are more likely to experience elevated social anxiety compared to matched healthy controls. Social anxiety will be assessed using the SAS-A, and the study will also explore whether environmental and sociodemographic factors such as tobacco smoke exposure, BMI, and parental education influence this relationship.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adolescents aged 12-18 years
Case group: Participants who will be diagnosed with primary headache according to InternationalClassification of Headache Disorders, 3rd edition (ICHD-3) criteria, confirmed by a pediatric neurologist
Control group: Participants who will have no history of recurrent headache or chronic physical/psychiatricillness
Disqualifiers
History of neurological disease other than primary headache
Any previously diagnosed psychiatric disorders
Regular use of psychotropic medications
Cognitive or developmental disabilities that would interfere with assessments
Trial population
Case group: Participants who will be diagnosed with primary headache according to InternationalClassification of Headache Disorders, 3rd edition (ICHD-3) criteria, confirmed by a pediatric neurologist Control group: Participants who will have no history of recurrent headache or chronic physical/psychiatricillness
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsGroup A: Case group
Group B: Control group
Trial outcomes
Primary outcomes
1
Total score on the Social Anxiety Scale for Adolescents (SAS-A)
The SAS-A, a self-administered 22-item Likert-scale questionnaire
Time frame
Day 1Secondary outcomes
1
Prevalence of clinically significant social anxiety (SAS-A = 50)
Classification based on SAS-A total score cut-off
Time frame
Day 12
Body Mass Index (BMI) differences between groups
BMI calculated as kg/m²
Time frame
Day 13
Parental smoking status
Self-report from caregiver; statistical comparison of SAS-A scores by smoking exposure
Time frame
Day 1Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: